Good News from Pfizer for Migraine Patients

Pfizer has received approval from the U.S. Food and Drug Administration for the use of the nasal spray "Zavzpret" to relieve migraines, which may provide patients with a fast-acting option for migraine pain relief. The drug "Zavzpret," also known as "Zavipitant," works to alleviate acute headaches, both with and without aura. The term "aura" refers to any neurological disturbance that occurs shortly before or during the onset of the migraine. Pfizer stated that the spray, which will have its price announced upon its launch in July, is expected to be priced similarly to other FDA-approved migraine medications.